Literature DB >> 12767097

Role of adjuvant cryosurgery in intralesional treatment of sacral tumors.

Yehuda Kollender1, Issac Meller, Jacob Bickels, Gideon Flusser, Josefin Issakov, Ofer Merimsky, Nissim Marouani, Alexander Nirkin, Avi A Weinbroum.   

Abstract

BACKGROUND: Cryosurgery is an adjuvant surgical technique for the treatment of benign aggressive, low-grade malignant and metastatic tumors of long bones. It has been used rarely to treat sacral tumors, mainly because of potential damage to nerves, blood vessels, and intrapelvic organs. The authors described their experience with this procedure and provided medium and long-term follow-up results.
METHODS: Fifteen procedures of cryosurgery of the sacrum were performed in 14 patients to improve the therapeutic outcome of a variety of tumors. The patient group included 7 males and 7 females with a mean age of 42 +/- 24 years. Three patients were younger than 20 years of age. The procedures were performed at the Tel Aviv Sourasky Medical Center between January 1991 and January 1999. There were seven benign aggressive lesions (four giant cell tumors and three aneurysmal bone cysts), one benign schwannoma, one low-grade chondrosarcoma, five metastatic carcinomas, and one high-grade Ewing sarcoma, all localized at level S(2) or higher. Eight of the bone tumors also involved significant anterior or posterior soft tissue. All patients had severe preoperative pain radiating to the buttocks, perineum, and lower limbs and 9 (64%) patients had bladder and/or rectal dysfunction. Invasive diagnostic procedures and radiation (if warranted) preceded surgery. Sacral posterior fenestration and burr drilling were followed by two-cycle cryosurgery using the open pour technique or the argon-helium-based heat-freeze system.
RESULTS: All interventions were performed under combined general and regional anesthesia and concluded uneventfully with moderate blood loss. Thirteen patients were discharged home after 8 +/- 5 days (one patient remained hospitalized for 30 days). Only two patients experienced local disease recurrence during a 3-11-year follow-up period: one was retreated successfully by cryosurgery and the other underwent sacrectomy and radiotherapy elsewhere, with a subsequent loss of visceral functions. No patient suffered chronic pain, deep wound infections, or significant neurologic deficits and all were satisfied with the esthetic outcome.
CONCLUSIONS: Cryosurgery is a conservative, feasible, and safe adjuvant technique in the treatment of sacral tumors. It is associated with minimal permanent neurologic and vascular injury compared with sacrectomy. Copyright 2003 American Cancer Society.

Entities:  

Mesh:

Year:  2003        PMID: 12767097     DOI: 10.1002/cncr.11383

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

Review 1.  Management of metastatic sacral tumours.

Authors:  Nasir A Quraishi; Kyriakos E Giannoulis; Kimberley L Edwards; Bronek M Boszczyk
Journal:  Eur Spine J       Date:  2012-06-23       Impact factor: 3.134

2.  Recurrence after and complications associated with adjuvant treatments for sacral giant cell tumor.

Authors:  Pietro Ruggieri; Andreas F Mavrogenis; Giuseppe Ussia; Andrea Angelini; Panayiotis J Papagelopoulos; Mario Mercuri
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

3.  Giant sacral schwannomas.

Authors:  Sedat Çağlı; Hasan Serdar Işık; Umut Yıldırım; Nevhis Akıntürk; Mehmet Zileli
Journal:  J Neurooncol       Date:  2012-07-18       Impact factor: 4.130

4.  Giant cell tumors of the sacrum--a nationwide study on midterm results in 26 patients after intralesional excision.

Authors:  L van der Heijden; M A J van de Sande; I C M van der Geest; H W B Schreuder; B J van Royen; P C Jutte; J A M Bramer; F C Öner; A P van Noort-Suijdendorp; H M Kroon; P D S Dijkstra
Journal:  Eur Spine J       Date:  2014-03-11       Impact factor: 3.134

5.  Curettage and cryosurgery for low-grade cartilage tumors is associated with low recurrence and high function.

Authors:  David G Mohler; Richard Chiu; David A McCall; Raffi S Avedian
Journal:  Clin Orthop Relat Res       Date:  2010-06-24       Impact factor: 4.176

Review 6.  The clinical approach toward giant cell tumor of bone.

Authors:  Lizz van der Heijden; P D Sander Dijkstra; Michiel A J van de Sande; Judith R Kroep; Remi A Nout; Carla S P van Rijswijk; Judith V M G Bovée; Pancras C W Hogendoorn; Hans Gelderblom
Journal:  Oncologist       Date:  2014-04-09

7.  Grade I chondrosarcoma of bone: the Münster experience.

Authors:  Arne Streitbürger; Helmut Ahrens; Maurice Balke; Horst Buerger; Winfried Winkelmann; Georg Gosheger; Jendrik Hardes
Journal:  J Cancer Res Clin Oncol       Date:  2008-10-15       Impact factor: 4.553

8.  Surgical treatment of cauda equina compression as a result of metastatic tumours of the lumbo-sacral junction and sacrum.

Authors:  Nasir A Quraishi; K E Giannoulis; S R Manoharan; K L Edwards; B M Boszczyk
Journal:  Eur Spine J       Date:  2012-12-18       Impact factor: 3.134

9.  Clinical presentation, management and outcomes of sacral metastases: a multicenter, retrospective cohort study.

Authors:  Raphaële Charest-Morin; Charles G Fisher; Ann L Versteeg; Arjun Sahgal; Peter Pal Varga; Daniel M Sciubba; James M Schuster; Michael H Weber; Michelle J Clarke; Laurence D Rhines; Stefano Boriani; Chetan Bettegowda; Michael G Fehlings; Paul M Arnold; Ziya L Gokaslan; Nicolas Dea
Journal:  Ann Transl Med       Date:  2019-05

10.  The unresolved case of sacral chordoma: from misdiagnosis to challenging surgery and medical therapy resistance.

Authors:  Fabio Garofalo; Dimitrios Christoforidis; Pietro G di Summa; Béatrice Gay; Stéphane Cherix; Wassim Raffoul; Nicolas Demartines; Maurice Matter
Journal:  Ann Coloproctol       Date:  2014-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.